CDX2 expression was observed in ovarian mucinous adenocarcinoma with well‐ and moderately differentiated types, whereas expression was negative or faint in other histological types (Table 2, Fig. 1A and B). Here, CDX2 is linked to ovarian mucinous adenocarcinoma.